Price target
28.050.00 0.00%
The 13 analysts offering 1 year price forecasts for 0RN3 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to 0RN3 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0RN3 EPS for the last quarter is −0.01 EUR despite the estimation of 0.01 EUR. In the next quarter EPS is expected to reach 0.19 EUR. Track more of TAKEDA PHARMACEUTICAL CO LTD NPV financials and stay on top of what is up with the company.
In the next quarter TAKEDA PHARMACEUTICAL CO LTD NPV revenue is expected to reach 6.30 B EUR. Check out TAKEDA PHARMACEUTICAL CO LTD NPV revenue and earnings and make informed decisions.
According to analysts, 0RN3 price target is 28.05 EUR with a max estimate of 32.98 EUR and a min estimate of 24.73 EUR. Check if this forecast comes true in a year, meanwhile watch TAKEDA PHARMACEUTICAL CO LTD NPV stock price chart and keep track of the current situation with 0RN3 news and stock market news.
We've gathered opinions of 15 analysts rating 0RN3 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.